Santa Clara, CA 11/3/14; Santa Clara, 11/20/14—Agilent Technologies has announced that beginning with the current quarter, the first quarter of its fiscal year 2015, it will report in three new divisions: the Life Sciences and Applied Markets Group (LSAG), the Diagnostics and Genomics Group (DGG), and the Agilent CrossLab Group (see IBO 9/30/14). “The organization we’re announcing today is about serving our customers with ease, efficiency and a single voice,” stated Mike McMullen, Agilent president, COO and CEO-elect. “By combining our businesses around market needs, rather than technologies, we provide our customers with an easier, more direct way to get the products, software and services they need.” Patrick Kaltenbach has been named senior vice president, Agilent, and president of LSAG, which combines the former Chemical Analysis and Life Sciences Groups. He was most recently vice president and general manager of Life Sciences Products and Solutions. Jacob Thaysen has been named senior vice president, Agilent, and president of DGG. Most recently, he was vice president and general manager of DGG after joining Agilent with the acquisition of Dako (see IBO 5/31/12). He replaces Fred Strohmeier, who will retire in the fiscal second quarter. Earlier this month, Agilent completed the spin-off of Keysight Technologies, its electronic measurement business (see IBO 9/30/14), which began trading on the New York Stock Exchange on November 3.